Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis [NA]

View source ↗

Summary

An ongoing trial to evaluate the effectiveness and safety of a TYK2 inhibitor in adults with moderate to severe plaque psoriasis is currently recruiting, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Unspecified TYK2 inhibitor (TYK2 inhibitor)

Snippet

Sponsor: Usynova Pharmaceuticals Ltd. | Conditions: Plaque Psoriasis, Moderate to Severe Plaque Psoriasis | NA | Status: RECRUITING